THE PREVALENCE AND CLINICAL MANIFESTATIONS OF TUBERCULOSIS AND THE EFFICIENCY OF ITS TREATMENT IN PATIENTS WITH DIABETES MELLITUS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives data on the prevalence of tuberculosis concurrent with diabetes mellitus in different regions of the world and on the clinical, radiological, and laboratory manifestations of this disease.

Full Text

Restricted Access

About the authors

O. Komissarova

Central Research Institute of Tuberculosis; N.I. Pirogov Russian National Research Medical University

Professor MD Moscow

R. Abdullaev

Central Research Institute of Tuberculosis

Email: rizvan0403@yandex.ru
Professor MD Moscow

O. Konyaeva

Central Research Institute of Tuberculosis

Moscow

O. Berezhnaya

Central Research Institute of Tuberculosis; N.I. Pirogov Russian National Research Medical University

Moscow

A. Mikhailovsky

Orenburg Regional Clinical Tuberculosis Dispensary

References

  1. WH0/HTM/TB/2015.22 Global Tuberculosis report 2015. [Electronic resource] //URL: http://www.who.int/tb/publications/global_report/en.
  2. Нечаева О.Б. Предварительные результаты эпидемиологических показателей по туберкулезу за 2015 год. [Электронный ресурс]: http://www.mednet. ru/ru/czentr-monitoringa-tuberkuleza.html
  3. IDF Diabetes Atlas. Seventh Edition revision 2015 [Electronic resource] URL: http://www.idf.org/diabetesatlas
  4. Дедов И.И., Шестакова М.В. Алгоритм специализированной медицинской помощи больным сахарным диабетом // Сахарный диабет. - 2015; 1: 1-112.
  5. Госрегистр СД Данные 2000-2015. [Электронный ресурс]: http:// diaregistry.ru
  6. Corbett E., Watt C., Walker N. et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic // Arch. Intern. Med. - 2003; 169: 1009-21.
  7. Декларация Бали о надвигающиеся ко-эпидемии: туберкулез и сахарный диабет. [Электронный ресурс]: http://www.worlddiabetesfoundation.org/ news/bali-declaration-calls-action-against-tb-diabetes-co-epidemic
  8. Комиссарова О.Г. Туберкулез легких у больных сахарным диабетом // Туберкулез и болезни легких. - 2012; 11: 3-7.
  9. Leung C., Lam T., Chan W. et al. Diabetic Control and Risk of Tuberculosis: A Cohort Study // Am. J. Epidemiol. - 2008; 167: 1486-94.
  10. Dooley K., Chaisson R. Tuberculosis and diabetes mellitus: convergence of two epidemics // Lancet Infect. Dis. - 2009; 9: 737-46.
  11. Смурова Т.Ф., Ковалева С.И. Туберкулез и сахарный диабет / М.: Медкнига, 2007; 317 с.
  12. Niazi A., Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control // J. Diabet. Metabol. Disord. - 2012; 11: e28.
  13. van Crevel R., Beiger M. Ottenhoff T. et al. Possible mechanisms underlying increased susceptibility of diabetes patients to TB // Int. J. Tuberc. Lung Dis. -2014; 18 (Suppl. 1): S5.
  14. Martens G., Arikan M., Lee J. et al. Tuberculosis Susceptibility of Diabetic Mice // Am. J. Repir. Cell Molecul. Biol. - 2007; 37: 518-24.
  15. Restrepo B., Fisher-Hoch S., Pino P. Tuberculosis in Poorly Controlled Type Diabetes: Altered Cytokine Expression in Peripheral White Blood Cells // Clin. Infect. Dis. - 2008; 47: 634-41.
  16. Yamashiro S., Kawakami K., Uezu K. et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis // Clin. Exp. Immunol. - 2005; 139: 57-64.
  17. Al-Attiyah R., Mustafa A. Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects // Clin. Exp. Immunol. - 2009; 158: 64-73.
  18. Костенко А.Д. Хирургическое и консервативное лечение больных туберкулезом в сочетании с сахарным диабетом. Автореф. дис.. канд. мед наук. М., 2003; 16 с.
  19. Alisjahbana B., Sahiratmadja E., Nelwan E. et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis // Clin. Infect. Dis. - 2007; 45: 428-35.
  20. Tatar D., Senol G., Alptekin S. et al. Tuberculosis in diabetics: features in an endemic area // Jpn. J. Infect. Dis. - 2009; 62: 423-7.
  21. Wu Z., Guo J., Huang Y. et al. Impact of diabetes mellitus on clinical presentation and treatment outcome of pulmonary tuberculosis in an urban area in China // Int. J. Tuberc. Lung Dis. - 2014; 18 (Suppl. 1): S240.
  22. Costa J., Gomes M., Duarte R. Diabetes mellitus and pulmonary tuberculosis - Portuguese retrospective cohort // Eur. Resp. Dis. - 2015; 46 (Suppl. 59): 2723.
  23. Abdulrazaq M., Alfarttoosi A. Prevalence of diabetes mellitus in new tuberculosis cases in Baghdad // Eur. Resp. Dis. - 2015; 46 (Suppl. 59): 2726.
  24. Balakrishnan S., Vijayan S., Nair S. et al. High diabetes prevalence among tuberculosis cases in Kerala, India // PLoS Med. - 2012; 7: e46502.
  25. Perez-Guzman C., Torres-Cruz A., Villarreal-Velarde H. et al. Progressive age-related changes in pulmonary tuberculosis images and the effect of diabetes // Am. J. Respir. Crit. Care Med. - 2000; 162: 1738-40.
  26. Комиссарова О.Г., Коняева О.О., Бережная О.О. и др. Сравнительный анализ клинических проявлений туберкулеза легких с лекарственной устойчивостью возбудителя у больных с сопутствующим сахарным диабетом и без него // Туберкулез и болезни легких. - 2015; 6: 80.
  27. Skowronski M., Zozulinska-Ziolkiewicz D., Barinow-Wojewodzki A. Tuberculosis and diabetes mellitus - an underappreciated association // Arch. Med. Sci. - 2014; 10: 1019-27.
  28. Dooley K. Impact of Diabetes Mellitus on Treatment Outcomes of Patients with Active Tuberculosis // Am. J. Trop. Med. Hyg. - 2009; 80: 634-9.
  29. Dye C., Glaziou P., Floyd K. et al. Prospects for tuberculosis elimination // Ann. Rev. Public Health. - 2013; 34: 271-86.
  30. Ковалева С.И. Сахарный диабет и туберкулез (диспансерное исследование). Автореф. дис.. д-ра мед наук. М., 1979; 36 с.
  31. Singla R., Khan N., Al-Sharif N. et al. Influence of diabetes on manifestations and treatment outcome of pulmonary TB patients // Int. J. Tuberc. Lung Dis. - 2006; 10: 74-9.
  32. Perez-Guzman C., Torres-Cruz A., Villarreal-Velarde H. et al. Atypical radiological images of pulmonary tuberculosis in 192 diabetic patients: a comparative study // Int. J. Tuberc. Lung Dis. - 2001; 5: 455-61.
  33. Комиссарова О.Г. Коняева О.О., Бережная О.О. и др. Особенности течения туберкулеза легких у больных с сопутствующим сахарным диабетом // Фтизиат. и пульмонол. - 2016; 1: 42-4.
  34. Punga V., Yakimova M., Rusakova L. Impact of diabetes mellitus on epidemiological rates of pulmonary tuberculosis // Int. J. Tuberc. Lung Dis. - 2014; 18 (Suppl. 1): S308.
  35. Chiang C., Bai K., Lin H. et al. The Influence of Diabetes, Glycemic Control, and Diabetes-Related Comorbidities on Pulmonary Tuberculosis // PLoS One. -2015; 10: e0121698.
  36. Zhang Q., Xiao H., Sugawara I. Tuberculosis complicated by Diabetes Mellitus of Shanghai Pulmonary Hospital, China // Jpn. Infect. Dis. - 2009; 62: 390-1.
  37. Baker M., Harries A., Jeon C. et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review // BMC Medicine. - 2011; 9: e81.
  38. Jimenez-Corona M., Cruz-Hervert L., Garcia-Garcia L. et al. Association of diabetes and tuberculosis: impact on treamtent and post-treatmentoutcomes // Thorax. - 2013; 68: 214-20.
  39. Chiang C., Lee J., Yu M. et al. Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death // Int. J. Tuberc. Lung Dis. - 2009; 13: 105-11.
  40. Park S., Shin J., Kim J. et al. The effect of diabetic control status on the clinical features of pulmonary tuberculosis // Eur. J. Clin. Microbiol. Infect Dis. -2012; 31: 1305-10.
  41. Rekha V., Balasubramanian R., Swaminathan S. et al. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors // Indian J. Med. Res. - 2007; 126: 452-8.
  42. Черных Н.А. Эффективность интенсивной химиотерапии туберкулеза легких у больных сахарным диабетом. Автореф. дис.. канд. мед. наук. М., 2004; 21 с.
  43. Комиссарова О.Г. Коняева О.О., Бережная О.О. и др. Эффективность лечения больных туберкулезом легких с множественной и широкой лекарственной устойчивостью возбудителя в сочетании с разными типами сахарного диабета // Вестник РГМУ. - 2015; 3: 33-7.
  44. Ruslami R., Nijland H., Adhiarta I. et al. Pharmacokinetics of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes // Antimicrob. Agents Chemother. - 2010; 54: 1068-74.
  45. Babalik A., Ulus I., Bakirci N. et al. Plasma concentrations of isoniazid and rifampin are decreased in adult pulmonary tuberculosis patients with diabetes mellitus // Antimicrob. Agents Chemother. - 2013; 57: 5740-2.
  46. Wang C., Yang C., Chen H. et al. Impact of type 2 diabetes on manifestation and treatment outcome of pulmonary tuberculosis // Epidemiol. Infect. - 2009; 137: 203-10.
  47. Oursler K., Moore R., Bishai W. Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors // Clin. Infect. Dis. -2002; 34: 752-9.
  48. Reed G., Choi H., Lee S. et al. Impact of diabetes and smoking on mortality in tuberculosis // PLoS One. - 2013; 8: e58044.
  49. Fielder J., Chaulk C., Dalvi M. et al. A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: implications for acceptable treatment success rates // Int. J. Tuberc. Lung Dis. - 2002; 6: 1114-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies